Fluorescence-Tagged Gold Nanoparticles for Rapidly Characterizing the Size-Dependent Biodistribution in Tumor Models
Nanoparticle vehicles may improve the delivery of contrast agents and therapeutics to diseased tissues, but their rational design is currently impeded by a lack of robust technologies to characterize their in vivo behavior in real‐time. This study demonstrates that fluorescent‐labeled gold nanoparti...
Saved in:
Published in: | Advanced healthcare materials Vol. 1; no. 6; pp. 714 - 721 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Weinheim
WILEY-VCH Verlag
01-11-2012
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Nanoparticle vehicles may improve the delivery of contrast agents and therapeutics to diseased tissues, but their rational design is currently impeded by a lack of robust technologies to characterize their in vivo behavior in real‐time. This study demonstrates that fluorescent‐labeled gold nanoparticles can be optimized for in vivo detection, perform pharmacokinetic analysis of nanoparticle designs, analyze tumor extravasation, and clearance kinetics in tumor‐bearing animals. This optical imaging approach is non‐invasive and high‐throughput. Interestingly, these fluorescent gold nanoparticles can be used for multispectral imaging to compare several nanoparticle designs simultaneously within the same animal and eliminates the host‐dependent variabilities across measured data. Together these results describe a novel platform for evaluating the performance of tumor‐targeting nanoparticles, and provide new insights for the design of future nanotherapeutics.
Fluorescence‐tagged gold nanoparticles are engineered for in vivo detection. These particles are used for in vivo pharmacokinetics analysis of nanoparticle designs, and to study the size‐dependent uptake of nanoparticles into tumors. Multispectral imaging of gold nanoparticles in vivo is demonstrated. The study builds a basis for high‐throughput head‐to‐head evaluation of nanoparticle formulations in vivo. |
---|---|
Bibliography: | ark:/67375/WNG-JZ0FKKZW-D istex:428765F4137C9DDBF8DF7CFCFE966E981475F32D ArticleID:ADHM201200084 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2192-2640 2192-2659 |
DOI: | 10.1002/adhm.201200084 |